For Laboratory Research Use Only
This product is a reference compound for in-vitro research only. Not for human consumption, diagnostic, or therapeutic use. Not a drug or supplement. Sold only to qualified researchers and institutions.

Healing & Recovery
Pentadecapeptide BPC-157
Synthetic 15-amino-acid sequence reference compound. Lyophilized white powder for in-vitro research use only.
per 10mg vial
Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Store lyophilized powder at -20°C, protected from light and moisture.
Note: All handling guidance is for laboratory use only. We do not provide use, dosing, or administration instructions.
A batch-specific Certificate of Analysis (COA) is included with every order. Third-party COAs available upon request.
Synthetic multi-agonist peptide reference compound. Lyophilized white powder for in-vitro research use only.
≥99% purity
$70
Synthetic 16-amino-acid mitochondrial-derived peptide reference compound. Lyophilized powder for in-vitro use.
≥99% purity
$200
Small-molecule quinolinium reference compound (NNMT inhibitor scaffold). Crystalline powder for in-vitro research use only.
≥99% purity
$60
No. This BPC-157 is a research reference compound sold for laboratory research use only (RUO). It is not a drug, supplement, or food, and it is not intended for human or veterinary administration, diagnosis, or therapeutic use.
Each 10mg vial is assayed to ≥99% purity by HPLC with identity confirmed by mass spectrometry, and ships with a batch-specific Certificate of Analysis matched to the vial lot number.
BPC-157 carries CAS number 137525-51-0, with molecular formula C62H98N16O22 and a molecular weight of approximately 1419.5 g/mol. Full parameters are listed on the data sheet.
Store the unopened lyophilized vial as described in the included documentation. Solvent compatibility, aliquoting, and reconstituted-state shelf-life guidance for laboratory handling are detailed in the storage and reconstitution guide.
Published studies are confined to in vitro and rodent models, where the peptide has been associated with angiogenesis-related signaling and tissue-repair endpoints. These observations are limited to non-human experimental systems and do not support any human use claim.